|
Re: FDA greenlights Eli Lilly COVID-19 combo therapy
|
9
|
Resverlogix Corp.
|
Mar 10, 2021 08:23PM
|
|
Re: Article
|
9
|
Resverlogix Corp.
|
May 29, 2022 04:26PM
|
|
Re: Forest plot
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 12:55PM
|
|
Re: Kidney data rocks!
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 01:17PM
|
|
Re: when Don said this might slide into April
|
9
|
Resverlogix Corp.
|
Mar 30, 2021 05:07PM
|
|
Meaning of MACE in the BTD
|
9
|
Resverlogix Corp.
|
Feb 18, 2020 07:30PM
|
|
Re: Finance
|
9
|
Resverlogix Corp.
|
May 25, 2020 05:48PM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
9
|
Resverlogix Corp.
|
Jun 13, 2020 05:15PM
|
|
Re: My Non-Scientific Net-Net Preliminary Conclusions
|
9
|
Resverlogix Corp.
|
Nov 16, 2019 02:42PM
|
|
Re: BOOM there it is
|
10
|
Resverlogix Corp.
|
Apr 07, 2021 07:49PM
|
|
Re: 8 Minutes at AHA
|
10
|
Resverlogix Corp.
|
Oct 25, 2019 02:52PM
|
|
Re: Shake it Up!
|
10
|
Resverlogix Corp.
|
Dec 23, 2020 08:46AM
|
|
Re: Epigenetics
|
10
|
Resverlogix Corp.
|
Feb 13, 2022 05:48PM
|
|
Re: 0.05 P-values -- A bridge too far ?
|
10
|
Resverlogix Corp.
|
Feb 12, 2020 04:03PM
|
|
Re: Just back from IR,...
|
10
|
Resverlogix Corp.
|
Oct 27, 2019 10:24AM
|
|
Re: The problem...as I see it
|
10
|
Resverlogix Corp.
|
Oct 17, 2020 03:20PM
|
|
Re: SF
|
10
|
Resverlogix Corp.
|
Sep 16, 2020 06:32PM
|
|
Re: Biotech Valuation
|
10
|
Resverlogix Corp.
|
Mar 30, 2021 04:59PM
|
|
Re: December 22, 2020.
|
10
|
Resverlogix Corp.
|
Oct 09, 2020 06:14PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
10
|
Resverlogix Corp.
|
Dec 22, 2020 04:02PM
|
